Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - NetLoans - NetMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Non-Current Debt (2016 - 2021)

Creative Medical Technology Holdings has reported Non-Current Debt over the past 6 years, most recently at $52582.0 for Q2 2021.

  • Quarterly Non-Current Debt rose 18546.1% to $52582.0 in Q2 2021 from the year-ago period, while the trailing twelve-month figure was $52582.0 through Jun 2021, up 18546.1% year-over-year, with the annual reading at $18782.0 for FY2020, 22804.88% up from the prior year.
  • Non-Current Debt was $52582.0 for Q2 2021 at Creative Medical Technology Holdings, up from $5082.0 in the prior quarter.
  • Over five years, Non-Current Debt peaked at $198082.0 in Q4 2018 and troughed at $82.0 in Q4 2019.
  • The 5-year median for Non-Current Debt is $11282.0 (2020), against an average of $35057.7.
  • Biggest five-year swings in Non-Current Debt: plummeted 99.96% in 2019 and later soared 22804.88% in 2020.
  • Tracing CELZ's Non-Current Debt over 5 years: stood at $25000.0 in 2017, then skyrocketed by 692.33% to $198082.0 in 2018, then plummeted by 99.96% to $82.0 in 2019, then soared by 22804.88% to $18782.0 in 2020, then skyrocketed by 179.96% to $52582.0 in 2021.
  • According to Business Quant data, Non-Current Debt over the past three periods came in at $52582.0, $5082.0, and $18782.0 for Q2 2021, Q1 2021, and Q4 2020 respectively.